Plain-English translation of NCT07523685 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a handheld medical device called gammaCore that delivers gentle electrical stimulation to the vagus nerve—a major nerve in your neck that helps regulate stress and emotional responses. Researchers want to see if using this device at home can safely reduce PTSD symptoms over time. The device has already been approved by the FDA for treating migraines, but this study will be the first to examine whether it works for PTSD.
Current PTSD treatments help some people, but many patients continue to struggle with symptoms. This trial exists to explore a new option that might help reduce PTSD symptoms by calming the nervous system through stimulation of the vagus nerve.
You likely qualify if…
You likely don't qualify if…
You will start with a 4-week observation period where researchers track your baseline PTSD symptoms. Then you'll enter the 12-week treatment phase, during which you'll use the gammaCore device on the side of your neck twice daily for about 2 minutes each time, at home. You'll attend six study visits (some remote, some in person) for training, check-ins, and symptom assessments. Throughout the study, you'll complete questionnaires to help researchers measure any changes in your symptoms and monitor your safety.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States